When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CDTX - Cidara commences pivotal study of lead drug rezafungin
Cidara Therapeutics Inc.
The first patient has been dosed in a pivotal 462-subject Phase 3 clinical trial, ReSPECT, evaluating Cidara Therapeutics' (CDTX+0.9%) lead candidate rezafungin for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation.
More news on: Cidara Therapeutics, Inc., Healthcare stocks news,